1. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J, 2002, 20:750-762.
[2]
2. Kim JH, Lee SH, Park J, et al. Primary pulmonary non-Hodgkin's lymphoma. Jpn J Clin Oncol, 2004, 34:510-514.
[3]
3. Ishii Y, Tomita V, Takasaki H, et al. Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Hematol Oncol, 2012, 30:186-189.
[4]
4. Ahmed S, Kussic SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma:a clinical study of a rare disease. Eur J Cancer, 2004, 40:1320-1326.
[5]
5. Harris NL, Isaacson PG. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol, 1999, 111(1 Suppl 1):S126-132.
[6]
6. Kang HS, Lee HY, Kim JJ, et al. An unusual presentation of pulmonary mucosa-associated lymphoid tissue lymphoma as diffuse pulmonary infiltrates with spontaneous regression. Cancer Res Treat, 2014 Sep 15[Epub ahead of print]. http://dx.doi.org/10.4143/crt.2014.016.].
[7]
7. Kido T, Yatera K, Noguchi S, et al. Detection of MALT1 gene rearrangements in BAL fluid cells for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma. Chest, 2012, 141:176-182.
[8]
8. Santos IG, Marchiori E, Zanetti G, et al. Primary pulmonary mucosa-associated lymphoid tissue lymphoma computed tomography findings:a case report. Cases J, 2009, 2:6329.
[9]
9. Okamura I. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma. Int J Hematol, 2015, 101:46-51.
[10]
10. Wang L, Xia ZJ, Zhang YJ, et al. Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma. Tumour Biol, 2015, 36:6409-6416.
